# Molecular Characterizazion and Biological Samples Centralisation of Patients Affected by Oncoematolofic Pathology

> **NCT06304194** · NA · RECRUITING · sponsor: **Meyer Children's Hospital IRCCS** · enrollment: 340 (estimated)

## Conditions studied

- Oncologic Disease
- Hematologic Diseases

## Interventions

- **OTHER:** Analysis of biological samples

## Key facts

- **NCT ID:** NCT06304194
- **Lead sponsor:** Meyer Children's Hospital IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-05
- **Primary completion:** 2027-07-05
- **Final completion:** 2028-07-05
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06304194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06304194, "Molecular Characterizazion and Biological Samples Centralisation of Patients Affected by Oncoematolofic Pathology". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06304194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*